Publicacions en col·laboració amb investigadors/es de Great North Children's Hospital (2)

2017

  1. Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome

    Journal of Pediatrics, Vol. 189, pp. 72-78.e3

  2. Tocilizumab is a promising treatment option for therapy resistant juvenile localized scleroderma patients

    Journal of Scleroderma and Related Disorders, Vol. 2, Núm. 3, pp. 203-207